Literature DB >> 25104858

Haploidentical transplantation: the search for the best donor.

Rupert Handgretinger1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25104858      PMCID： PMC4126317          DOI： 10.1182/blood-2014-06-582460

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.

Authors:  Loredana Ruggeri; Antonella Mancusi; Marusca Capanni; Elena Urbani; Alessandra Carotti; Teresa Aloisi; Martin Stern; Daniela Pende; Katia Perruccio; Emanuela Burchielli; Fabiana Topini; Erika Bianchi; Franco Aversa; Massimo F Martelli; Andrea Velardi
Journal:  Blood       Date:  2007-03-19       Impact factor: 22.113

2.  Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.

Authors:  Jon J van Rood; Fausto R Loberiza; Mei-Jie Zhang; Machteld Oudshoorn; Frans Claas; Mitchell S Cairo; Richard E Champlin; Robert Peter Gale; Olle Ringdén; Jill M Hows; Mary H Horowitz
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

3.  Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors.

Authors:  Wing Leung; Rekha Iyengar; Brandon Triplett; Victoria Turner; Frederick G Behm; Marti S Holladay; James Houston; Rupert Handgretinger
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

4.  KIR haplotype B donors but not KIR-ligand mismatch result in a reduced incidence of relapse after haploidentical transplantation using reduced intensity conditioning and CD3/CD19-depleted grafts.

Authors:  Sebastian U Michaelis; Markus Mezger; Martin Bornhäuser; Rudolf Trenschel; Gernot Stuhler; Birgit Federmann; Lena Oevermann; Lothar Kanz; Rupert Handgretinger; Wolfgang A Bethge
Journal:  Ann Hematol       Date:  2014-04-26       Impact factor: 3.673

5.  Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center.

Authors:  Yu Wang; Dai-Hong Liu; Kai-Yan Liu; Lan-Ping Xu; Xiao-Hui Zhang; Wei Han; Huan Chen; Yu-Hong Chen; Feng-Rong Wang; Jing-Zhi Wang; Yu-Qian Sun; Xiao-Jun Huang
Journal:  Cancer       Date:  2012-10-23       Impact factor: 6.860

6.  Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation.

Authors:  Heather J Symons; M Sue Leffell; Nancy D Rossiter; Marianna Zahurak; Richard J Jones; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2009-12-02       Impact factor: 5.742

7.  Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor.

Authors:  Martin Stern; Loredana Ruggeri; Antonella Mancusi; Maria Ester Bernardo; Claudia de Angelis; Christoph Bucher; Franco Locatelli; Franco Aversa; Andrea Velardi
Journal:  Blood       Date:  2008-05-20       Impact factor: 22.113

8.  Who is the best donor for a related HLA haplotype-mismatched transplant?

Authors:  Yu Wang; Ying-Jun Chang; Lan-Ping Xu; Kai-Yan Liu; Dai-Hong Liu; Xiao-Hui Zhang; Huan Chen; Wei Han; Yu-Hong Chen; Feng-Rong Wang; Jing-Zhi Wang; Yao Chen; Chen-Hua Yan; Ming-Rui Huo; Dan Li; Xiao-Jun Huang
Journal:  Blood       Date:  2014-06-10       Impact factor: 22.113

9.  T-cell alloreactivity dominates natural killer cell alloreactivity in minimally T-cell-depleted HLA-non-identical paediatric bone marrow transplantation.

Authors:  Eric J Lowe; Victoria Turner; Rupert Handgretinger; Edwin M Horwitz; Ely Benaim; Gregory A Hale; Paul Woodard; Wing Leung
Journal:  Br J Haematol       Date:  2003-10       Impact factor: 6.998
  9 in total
  2 in total

1.  Post-transplant bendamustine reduces GvHD while preserving GvL in experimental haploidentical bone marrow transplantation.

Authors:  Jessica Stokes; Emely A Hoffman; Yi Zeng; Nicolas Larmonier; Emmanuel Katsanis
Journal:  Br J Haematol       Date:  2016-03-31       Impact factor: 6.998

Review 2.  How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?

Authors:  Ying-Jun Chang; Leo Luznik; Ephraim J Fuchs; Xiao-Jun Huang
Journal:  J Hematol Oncol       Date:  2016-04-12       Impact factor: 17.388
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.